Changes in the ratios of stable nitric oxide metabolites in the exhaled breath condensate in patients with COPD during antioxidant therapy.
I. Klimanov (Moscow, Russian Federation), S. Soodaeva (Moscow, Russian Federation), N. Popova (Moscow, Russian Federation), T. Li (Moscow, Russian Federation), N. Kubysheva (Kazan, Russian Federation), L. Murakaeva (Moscow, Russian Federation), M. Glukhova (Moscow, Russian Federation), L. Nikitina (Moscow, Russian Federation)
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Klimanov (Moscow, Russian Federation), S. Soodaeva (Moscow, Russian Federation), N. Popova (Moscow, Russian Federation), T. Li (Moscow, Russian Federation), N. Kubysheva (Kazan, Russian Federation), L. Murakaeva (Moscow, Russian Federation), M. Glukhova (Moscow, Russian Federation), L. Nikitina (Moscow, Russian Federation). Changes in the ratios of stable nitric oxide metabolites in the exhaled breath condensate in patients with COPD during antioxidant therapy.. 4106
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005
Nitrite/nitrate levels in exhaled breath condensate are increased but exhaled nitric oxide levels were not in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006
Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 506s Year: 2002
The dynamics of Fe2+ and nitric oxide (NO) metabolites levels in exhaled breath condensate (EBC) in long-term smokers Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009
The effect of antioxidant therapy on nitric oxide metabolites in exhaled breath condensate in patients with pollen allergy and bronchial asthma Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III Year: 2007
The changes of nitric oxide metabolism and soluble forms of differentiated antigens levels in exhaled breath condensate (EBC) in Chernobyl clean-up workers with COPD Source: Annual Congress 2009 - Occupational exposures and disease II Year: 2009
Exhaled nitric oxide (eNO) and pH in the exhaled breath condensate in asthmatic children: biomarkers of different inflammatory pathways? Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008
Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
Hydrogen peroxide in exhaled breath condensate and exhaled nitric oxide as non-invasive markers for childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
The effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in the breath condensate of adults with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002
Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007
The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Content of nitric oxide in the exhaled breath condensate, induced sputum and BAL in asthma and COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 369s Year: 2006
Exhaled nitric oxide and exhaled breath condensate pH in smoking asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC) Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006
Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007
Concentration of nitric oxide in exhaled air (eNO) in patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002
Exhaled nitric oxide and carbon monoxide are not markers of disease activity in asthma patients on reducing doses of inhaled steroids: a longitudinal study Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001